DeCamillo D, Ellsworth S, Kaatz S, Barnes GD. Use of apixaban and rivaroxaban in young adults with acute venous thromboembolism: a multicenter retrospective case series. Journal of Thrombosis and Thrombolysis https://doi.org/10.1007/s11239-020-02095-7
Gruca, M.M., et al. J Thromb Thrombolysis. Creatinine monitoring patterns in the setting of direct oral anticoagulant therapy for non-valvular atrial fibrillation. October 2019, Volume 48, Issue 3, pp 500–505. https://doi.org/10.1007/s11239-019-01883-0
Schafer, Jordan, et al. Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse Events. JAMA Intern Med. doi:10.1001/jamainternmed.2018.7816
Kurlander J, et al. Missed Opportunities to Prevent Upper GI Hemorrhage: The Experience of the Michigan Anticoagulation Quality Improvement Initiative. Vasc Med. 2019 Feb 27:1358863X18815971. doi: 10.1177/1358863X18815971
Hughey AB, Gu X, Haymart B, Kline-Rogers E, Almany S, Kozlowski J, Besley D, Krol GD, Ahsan S, Kaatz S, Froehlich JB, Barnes GD. Warfarin for Prevention of Thromboembolism in Atrial Fibrillation: Comparison of Patient Characteristics and Outcomes of the "Real-World" Michigan Anticoagulation Quality Improvement Initiative (MAQI2) Registry to the RE-LY, ROCKET-AF, and ARISTOTLE Trials. J Thromb Thrombolysis. 2018 Oct;46(3):316-324. doi: 10.1007/s11239-018-1698-y.
G. D. Barnes X. Kong D. Cole B. Haymart E. Kline‐Rogers S. Almany M. Dahu M. Ekola S. Kaatz J. Kozlowski J. B. Froehlich Extended International Normalized Ratio Testing Intervals for Warfarin-treated Patients. Journal of Thrombosis and Haemostasis. 16: 1307–1312 DOI: 10.1111/jth.14150
Jacob E Kurlander, MD, MS, Geoffrey D Barnes, MD, MS, Michelle A. Anderson, MD, MSc, Brian Haymart, RN, MSc, Eva Kline-Rogers, NP, Scott Kaatz, DO, MSc, Sameer D Saini, MD, MS, Sarah L. Krein, PhD, RN, Caroline R. Richardson,MD, James B Froehlich, MD, MPH. Mind the gap: Results of a multispecialty survey on coordination of care for peri-procedural anticoagulation. J Thromb Thrombolysis. 2018 Apr;45(3):403-409. doi: 10.1007/s11239-018-1625-2.
Deborah DeCamillo, RN, BSN; Elizabeth Renner, PharmD. ICHECK’D: Mnemonic approach assists in caring for patients receiving direct oral anticoagulant. Cardiology Today, January 2018. https://goo.gl/Hpmjcr
Geoffrey D. Barnes, Sevan Misirliyan, Scott Kaatz, Elizabeth A. Jackson, Brian Haymart, Eva Kline-Rogers, Jay Kozlowski, Gregory Krol, James B. Froehlich and Anne Sales. Barriers and facilitators to reducing frequent laboratory testing for patients who are stable on warfarin: a mixed methods study of de-implementation in five anticoagulation clinics. Implementation Science 2017 12:87. DOI: 10.1186/s13012-017-0620-x
Christopher M. Graves, BA; Brian Haymart, RN, MS; Eva Kline-Rogers, MS, NP; Geoffrey D. Barnes, MD, MSc; Linda K. Perry, RN, BSN; Denise Pluhatsch, RN, BSN; Nannette Gearhart, RN, MSN; Helen Gikas, RN; Noelle Ryan, PharmD; Brian Kurtz, PharmD. Root Cause Analysis of Adverse Events in an Outpatient Anticoagulation Management Consortium. The Joint Commission Journal on Quality and Patient Safety 2017; 43:299–307
Barnes. Discontinuation of Warfarin Therapy for Patients With Atrial Fibrillation: The Michigan Anticoagulation Quality Improvement Initiative Experience. JAMA Cardiology Published online January 4, 2017
Jordan K. Schaefer, Suman L. Sood, Brian Haymart, Xiaokui Gu, Eva Kline-Rogers, Steven L. Almany, Jay H. Kozlowski, Gregory D. Krol, Scott Kaatz, James B. Froehlich and Geoffrey D. Barnes. Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants. Blood Advances. December 2017. Volume 1, Number 26.
Hale, Z. Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulant. Journal of Thrombosis and Thrombolysis. Nov. 2016.
Anum S. Minhas et al. Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant. J Thromb Thrombolysis (2016) 42:566–572
Geoffrey D. Barnes, Eva Kline-Rogers. Engaging with quality improvement in anticoagulation management. J Thromb Thrombolysis (2015) 39:403–409
Eric Puroll, Steven T. Heidt, Brian Haymart, James B. Froehlich, and Eva Kline-Rogers. AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative. Case Reports in Medicine Volume 2014 (2014). doi.org/10.1155/2014/754147
Geoffrey D. Barnes, Xiaokui Gu, Brian Haymart, Eva Kline-Rogers, Steve Almany, Jay Kozlowski, Dennis Besley, Gregory D. Krol, James B. Froehlich, Scott Kaatz. The Predictive Ability of the CHADS2 and CHA2DS2-VASc Scores for Bleeding Risk in Atrial Fibrillation: The MAQI2 Experience. Thrombosis Research 134 (2014) 294–299
Geoffrey D. Barnes, Scott Kaatz , Julia Winfield , Xiaokui Gu, Brian Haymart, Eva Kline-Rogers, Jay Kozlowski, Dennis Beasley, Steve Almany, Tom Leyden, James B. Froehlich. Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2). J Thromb Thrombolysis. 2013 May 8.
Barnes GD, Kaatz S, Golgotiu V, Gu X, Leidal A, Kobeissy A, Haymart B, Kline-Rogers E, Kozlowski J, Almany S, Leyden T, Froehlich JB. Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI(2)). J Throm Thrombolysis 2012; Jul 14
